NCT03461965

Brief Summary

Patients undergoing Mohs micrographic surgery (MMS) frequently experience anxiety. It has been suggested that enhanced patient education prior to the procedure may decrease patient anxiety. The purpose of the study is to investigate if optimized participant education enhances participant understanding, decreases participant anxiety and increases participant satisfaction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 2, 2018

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 5, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 12, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 25, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2019

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

May 21, 2021

Completed
Last Updated

May 21, 2021

Status Verified

April 1, 2021

Enrollment Period

11 months

First QC Date

March 5, 2018

Results QC Date

April 2, 2021

Last Update Submit

April 30, 2021

Conditions

Keywords

3D printingPatient education

Outcome Measures

Primary Outcomes (1)

  • Percent of Correct and Incorrect Mohs Quiz Responses

    This is an in-house-designed, short questionnaire with 6 multiple choice objective questions related to the participant's understanding of Mohs. A higher percentage of correct answers indicate a better understanding of Mohs. Reported data are percent of responses answered correctly and incorrectly totaled across all participants in each arm

    Post surgery (1 day)

Secondary Outcomes (4)

  • Change in State-Trait Anxiety Inventory (STAI) Y-1 (State Anxiety) Score

    From baseline to post surgery (1 day)

  • Change in Visual Analog Scale (VAS) Anxiety Score

    From baseline to post surgery (1 day)

  • Change in Visual Analog Scale (VAS) Understanding Score

    From baseline to post surgery (1 day)

  • Satisfaction Survey Score

    Post surgery (1 day)

Study Arms (2)

Education with 3D printed model

EXPERIMENTAL

The experimental group will be educated on MMS with a standardized script in addition to a 3D MMS model

Behavioral: 3D printed modelBehavioral: Verbal Counselling

Verbal Counselling

ACTIVE COMPARATOR

Participants in the control group will be educated on MMS according to the current standard of care, verbal counselling, with a standardized script

Behavioral: Verbal Counselling

Interventions

A printed 3D model of MMS will be created showing a model of skin, and a tumor to visually depict the surgery

Education with 3D printed model

Participants will be educated with a standardized script on skin cancer, risks for skin cancer, treatment options, and MMS

Education with 3D printed modelVerbal Counselling

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing MMS at University Hospitals Cleveland Medical Center, Chagrin Highlands and Westlake Campus
  • Capable of reading and completing all subjective questionnaires

You may not qualify if:

  • Cannot complete the survey measures independently for any reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Cleveland, Ohio, 44106, United States

Location

Results Point of Contact

Title
Dr. Margaret Mann, MD
Organization
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Study Officials

  • Margaret Mann, MD

    University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Patients will be recruited from University Hospitals Department of Dermatology MMS Clinics at the Cleveland Medical Center, Chagrin Highlands and Westlake Locations. These patients will be randomly assigned to a control (50%) or experimental group (50%) prior to the onset of the study protocol.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2018

First Posted

March 12, 2018

Study Start

March 2, 2018

Primary Completion

January 25, 2019

Study Completion

January 25, 2019

Last Updated

May 21, 2021

Results First Posted

May 21, 2021

Record last verified: 2021-04

Locations